ozempic vs glp-1 Agonists for Weight Loss: A Side-by-Side Comparison Understanding semaglutide (GLP-1 RA): Are

John Scott, MD, FACS, FASMBS, is the Director of the bariatric surgery program and chief of the Minimal Access and Bariatric Surgery division at Prisma Health

The present study emulated a target trial to avoid immortal time and selection bias, chose a second-line glucose-lowering therapy as an active comparator to reduce confounding by indication, used an outcome definition based only on primary care records to minimize detection bias due to differential hospitalizations, and implemented a lag time to mitigate bias due to reverse causality

Maida A, Hansotia T, Longuet C, Seino Y, Drucker DJ

At Newport Beach UC, every patient begins with a thorough health assessment

Broad Therapeutic Effects : Tirzepatide results in clinically significant improvements in multiple obesity-related complications, including sleep apnea, metabolic dysfunction-associated steatohepatitis, heart failure with preserved ejection fraction, and diabetes prevention [79]

Accordingly, the focus here is on general patterns rather than subgroup-specific mechanisms